Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

被引:111
作者
Sanz, C. [1 ,2 ]
Vazquez, P. [1 ,2 ,3 ]
Blazquez, C. [4 ,5 ]
Barrio, P. A. [1 ,2 ]
Alvarez, M. Del M. [1 ]
Blazquez, E. [1 ,2 ]
机构
[1] Univ Complutense, Dept Bioquim & Biol Mol, Fac Med, E-28040 Madrid, Spain
[2] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain
[3] CSIC, Ctr Invest Biol, Madrid, Spain
[4] Hosp La Princesa, Serv Hematol, Madrid, Spain
[5] Hosp Jerez, Serv Hematol, Jerez de la Frontera, Spain
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 298卷 / 03期
关键词
human mesenchymal stem cell; proliferation; adipogenesis; cytoprotection; FIBROBLAST-GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; ADIPOCYTE DIFFERENTIATION; IN-VIVO; DIABETES-MELLITUS; RAT-BRAIN; INNER-EAR; RECEPTOR; GLUCOSE; EXPRESSION;
D O I
10.1152/ajpendo.00460.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sanz C, Vazquez P, Blazquez C, Barrio PA, Alvarez MM, Blazquez E. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow. Am J Physiol Endocrinol Metab 298: E634-E643, 2010. First published December 29, 2009; doi:10.1152/ajpendo.00460.2009.-Glucagon-like peptide 1 (GLP-1) functions as an incretin hormone with antidiabetogenic properties. However, the role of GLP-1 in human bone marrow-derived mesenchymal stem cells (hMSCs), if any, remains unknown. The effects of GLP-1 on hMSCs were tested with regard to cell proliferation, cytoprotection, and cell differentiation into adipocytes. The signaling pathways involved in these processes were also analyzed. Cells were characterized with biochemical and morphological approaches before and after being induced to differentiate into adipocytes. PCNA protein levels were used as a proliferation index, whereas cell apoptosis was studied by deprivation of fetal bovine serum. Isolated hMSCs expressed stem cell markers as well as mRNA and GLP-1 receptor protein. GLP-1 increased the proliferation of hMSCs, which decreased when they were induced to differentiate into adipocytes. This process produced biochemical and morphological changes in cells expressing PPAR gamma, C/EBP beta, AP2, and LPL in a time-dependent pattern. Notably, GLP-1 significantly reduced the expression of PPAR gamma, C/EBP beta, and LPL. These effects were exerted at least through the MEK and PKC signaling pathways. In addition, GLP-1 significantly reduced cell apoptosis. Our data indicate that, in hMSCs, GLP-1 promotes cellular proliferation and cytoprotection and prevents cell differentiation into adipocytes. These latter findings underscore the potential therapeutic role of GLP-1 in preventing the adipocyte hyperplasia associated with obesity and, additionally, could bolster the maintenance of hMSC stores by promoting the proliferation and cytoprotection of undifferentiated hMSC.
引用
收藏
页码:E634 / E643
页数:10
相关论文
共 43 条
  • [1] Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes
    Abdi, Reza
    Fiorina, Paolo
    Adra, Chaker N.
    Atkinson, Mark
    Sayegh, Mohamed H.
    [J]. DIABETES, 2008, 57 (07) : 1759 - 1767
  • [2] The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
    Alvarez, E
    Martínez, MD
    Roncero, I
    Chowen, JA
    García-Cuartero, B
    Gispert, JD
    Sanz, C
    Vázquez, P
    Maldonado, A
    de Cáceres, J
    Desco, M
    Pozo, MA
    Blázquez, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) : 798 - 806
  • [3] Alvarez E, 1996, J NEUROCHEM, V66, P920
  • [4] The role of MAPKs in adipocyte differentiation and obesity
    Bost, F
    Aouadi, M
    Caron, L
    Binétruy, B
    [J]. BIOCHIMIE, 2005, 87 (01) : 51 - 56
  • [5] Cultured pancreatic ductal cells undergo cell cycle re-distribution and β-cell-like differentiation in response to glucagon-like peptide-1
    Bulotta, A.
    Hui, H.
    Anastasi, E.
    Bertolotto, C.
    Boros, L. G.
    Di Mario, U.
    Perfetti, R.
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (03) : 347 - 360
  • [6] Increased glucagon like peptide-1 receptor expression in glia after mechanical lesion of the rat brain
    Chowen, JA
    de Fonseca, FR
    Alvarez, E
    Navarro, M
    García-Segura, LM
    Blázquez, E
    [J]. NEUROPEPTIDES, 1999, 33 (03) : 212 - 215
  • [7] Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
    Conarello, SL
    Li, ZH
    Ronan, J
    Roy, RS
    Zhu, L
    Jiang, GQ
    Liu, F
    Woods, J
    Zycband, E
    Moller, DE
    Thornberry, NA
    Zhang, BB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6825 - 6830
  • [8] Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy
    De León, DD
    Deng, SP
    Madani, R
    Ahima, RS
    Drucker, DJ
    Stoffers, DA
    [J]. DIABETES, 2003, 52 (02) : 365 - 371
  • [9] Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
    de Rooij, J
    Zwartkruis, FJT
    Verheijen, MHG
    Cool, RH
    Nijman, SMB
    Wittinghofer, A
    Bos, JL
    [J]. NATURE, 1998, 396 (6710) : 474 - 477
  • [10] Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis
    Drucker, DJ
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (02) : 161 - 171